Background-Hypercholesterolemia protects against ventricular fibrillation in patients with myocardial infarction. We hypothesize that hypercholesterolemia protects against ischemia-induced reentrant arrhythmias because of altered ion channel function. 
H ypercholesterolemia is associated with high plasma levels of low-density lipoprotein (LDL) cholesterol and low levels of high-density lipoprotein (HDL) cholesterol. Hypercholesterolemia is a major risk factor for cardiovascular disease and can result in atherosclerosis and development of myocardial infarction (MI). 1 
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In a study by Dekker et al, it was demonstrated that in a patient group with acute MI followed by ventricular fibrillation (VF), hypercholesterolemia was significantly less present than in the patient group with acute MI without VF. This suggests that hypercholesterolemia protects against primary VF in patients with an MI. 2 The lipid composition of the myocyte membrane is an important modulator of ion channel function and thus of action potential (AP) configuration and has important implications for the genesis of cardiac arrhythmias. 3, 4 For example, a diet rich in fish oil shortens the ventricular AP in the absence of circulating fish oils. 5 Also, LDL lowering therapy is associated with a shortening of the QT interval in patients with advanced chronic heart failure, 6 and infusion of reconstituted high-density lipoprotein cholesterol causes a shortening of the QT-interval in patients with hypercholesterolemia. 7 On the contrary, in obese patients with high levels of cholesterol, 8 the electrocardiographic QT segment is prolonged, which may protect them from primary VF. Prolongation of the QT segment is a result of prolongation of the ventricular AP caused by altered ion channel function and may provoke arrhythmias caused by triggered activity, 9 but may antagonize (ischemia-induced) reentrant arrhythmias. 10 Indeed, in an animal model of heart failure, 11 a diet rich in fish oil protected against arrhythmias caused by triggered activity based on early after-depolarizations, but facilitated the occurrence of reentrant arrhythmias. 12 We surmise that cholesterol directly modulates cardiac electrophysiology and arrhythmogenesis in the absence of structural abnormalities resulting from atherosclerosis. We thus hypothesize that both increased levels of serum LDL and decreased levels of serum HDL cholesterol lead to increased membrane cholesterol, prolong the ventricular AP duration, and thereby protect from reentrant arrhythmias (during acute myocardial ischemia).
Methods
This study was approved by the local institutional ethical committee. Animal care and handling conformed to the Guide for Care and Use of Laboratory Animals published by the US National Institutes of Health (NIH Publication No. 85-23, revised 1996).
Design of the Study
We used 2 validated dyslipidemic mouse models without structural cardiac changes and atherosclerosis: (1) LDL receptor knockout mouse (LDLr −/− ) that recapitulates human patients with elevated serum LDL cholesterol 13 and (2) the apolipoprotein A1 knockout mouse (ApoA1 −/− mice) that recapitulates human patients with decreased serum HDL cholesterol levels.
14 Wild-type mice (WT) were used as control. Male and female ApoA1 −/− (B6;129P2-ApoA1 tm1umc /J)-and LDLr −/− (B6;129S7-LDLr tm1 Her/J)-deficient mice and WT mice (C57BL/6J) were purchased from Jackson Laboratories. The dyslipidemic mouse strains had been backcrossed to C57BL/6J mice for 10 generations. Only 10-week-old male were used for experiments.
The animals were anesthetized by isoflurane inhalation (0.8%-1.0% volume), and a 6 lead surface ECG was measured. Then the mice were killed by cervical dislocation. The chest was opened and an incision was made in the aorta to collect blood for plasma cholesterol analysis. The heart was excised and used for either expression or functional studies.
Isolation of left ventricular myocytes was performed as described previously. 15 Myocytes were stored at room temperature, about 10 
ECG Measurements
Surface ECGs were recorded using subcutaneous 23-gauge needle electrodes attached to each limb. Lead I was analyzed for heart rate, PQ, QRS, and QT duration. QT intervals were corrected for heart rate using the formula QTc=QT/((RR/100) 1/2 ) with RR in ms, which is a mouse equivalent of Bazett's formula. 16 Criteria for QRS duration were applied according to Boukens et al.
17

Plasma Cholesterol and Sphingolipid Content in Left Ventricular Myocytes
Plasma total and HDL cholesterol were measured by enzymatic colorimetric spectrophotometry. LDL cholesterol was calculated with the Friedewald formula. 18 Tissue cholesterol and sphingolipids were measured in myocytes as described previously. 19 Myocytes from 2 hearts were pooled for reasons of sensitivity.
[Ca
2+
] i and Sarcoplasmic Reticulum Calcium Content [Ca 2+ ] i transients and sarcoplasmic reticulum (SR) calcium content were measured in left ventricular myocytes using Indo-1 as described previously. 20 [Ca 2+ ] i transients (6 Hz) were measured at 37°C using field stimulation, and SR calcium content was estimated from the response of [Ca 2+ ] i to rapid cooling (RC). Fractional SR calcium release was estimated from the ratio of [Ca 2+ ] i increase during a calcium transient and during RC 21 (see Data Supplement).
Inducibility of Arrhythmias During Ischemia in Langendorff-Perfused Hearts
Inducibility of arrhythmias was tested in WT, LDLr −/− , and ApoA1 −/− hearts (25, 20 , and 19 hearts, respectively). After cannulation of the aorta, hearts were allowed to recover for 15 minutes at 37°C with a solution containing in mM NaCl 128, KCL 4.7, CaCl 2 1.45, MgCl 2 0.6, NaHCO 3 27, NaH 2 PO 4 0.4, and glucose 11, which was gassed with 95% O 2 and 5% CO 2 (pH 7.4). A 30 minutes period of regional ischemia was induced by ligation of the left anterior descending artery (1 mm beneath its origin). From the last 5 minutes of the control period onward, the hearts were stimulated via a bipolar pacing electrode placed on the right ventricle with a basic cycle length of 120 ms. (1 ms pulse duration, twice diastolic stimulation threshold).
Electrograms were recorded via a unipolar electrode placed on the left ventricle, with a reference electrode placed on the cannula. The inducibility of arrhythmias during ischemia was tested every 30 s (60 attempts/heart) by applying a train of 3 shortly coupled stimuli set 10 ms beyond the corresponding refractory period, followed by a pause of 500 ms (timing of the stimuli was determined before ischemia). The number and type of spontaneous arrhythmias after the 3 premature beats were documented. Ventricular tachycardia (VT) was defined as a spontaneous rhythm occurring with a cycle length below 90 ms containing regular monomorphic sequences. VF was defined as a spontaneous polymorphic irregular rhythm. When VF occurred, stimulation was stopped, and 20 seconds were allowed for the spontaneous termination of the arrhythmia. If the arrhythmia did not terminate spontaneously, the heart was defibrillated by an injection of ice-cold Tyrode's solution. Then the heart was allowed to recover for 2 minutes and the stimulation protocol was resumed.
To determine the volume of the ischemic tissue, the heart was perfused after the experiment with 0.2% Evans Blue and stored in 4% buffered formalin after which the hearts were embedded in 4% agarose and cut into 5 transversal slices for microscopic analysis. The relative ischemic volume (RIV%) was calculated by dividing the cumulated area of the ischemic tissue by the left ventricular cumulative area.
WHAT IS KNOWN
• Hypercholesterolemia protects against ventricular fibrillation in patients with myocardial infarction.
• Sarcolemmal lipid composition of cardiac myocytes is an important modulator of ion channel function and arrhythmogenesis.
WHAT THE STUDY ADDS
• Increased sarcolemmal cholesterol of cardiac myocytes was associated with increased L-type calcium channel current density, prolonged action potential and QTc interval duration.
• Hearts from hypercholesterolemic mice were protected from reentrant arrhythmias during acute myocardial ischemia.
• Clinical cholesterol modulating regimens affect the susceptibility to life threatening arrhythmias.
Cellular Electrophysiology
AP and sarcolemmal ion currents were recorded in left ventricular myocytes at 36±0.2°C with the amphotericin-B-perforated patchclamp and ruptured patch-clamp technique, respectively. 22 Steady-state currents negative to -40 mV were defined as inward rectifier K + current (I K1 ) and steadystate currents positive to -40 mV as the noninactivating K V current (I ss ). The decay phases of the transient currents activated on depolarization described the sum of 2 exponentials, reflecting the inactivating currents I to,f and I K,slow 22 (see Data Supplement).
Expression
Quantitative Real-Time Polymerase Chain Reaction RNA (1 μg) isolated from flash-frozen apex was reverse-transcribed using Oligo(dT) primers and Superscript II reverse transcriptase (Invitrogen). Real-time polymerase chain reaction was performed in 384-well plates using SYBR Green I master solution (Roche) and the LightCycler 480 (Roche). Polymerase chain reaction amplification was performed in a total reaction volume of 10 μL, consisting of 1 μM forward and reverse primers, 2 μL cDNA, 5 μL 2× SYBR Green. The polymerase chain reaction was cycled between 95°C/30 s and 60°C/30 s for 50 cycles after an initial denaturation step at 95°C for 5 minutes. Primers were specific for mouse sequences and designed as described in detail before. 24 Transcript quantities were normalized to the amount of endogenous control (Hprt and Gapdh) and analyzed using LinRegPCR software 25 (see Data Supplement).
Western Blot Analysis
Heart lysates were extracted from flash-frozen mouse hearts in radioimmunoprecipitation assay buffer (25 mmol/L Tris-HCl, pH 7.6, 150 mmol/L NaCl, 1% NP40, 1% sodium deoxycholate, 0.1% sodium dodecyl sulfate) as described previously 26 (see Data Supplement).
Statistics
Statistical analysis was performed with SigmaStat 3.5 software, and data are presented as mean±SEM. Normality and equal variance assumptions were tested with the Kolmogorov-Smirnov and the Levene median test, respectively. Groups were compared using 1-way ANOVA, or Z-test when appropriate, and for I-V relationships by 2-way repeated measures ANOVA followed by the Student Newman-Keuls post hoc test. P<0.05 was considered statistically significant. The results obtained with the above procedure are consistent with a nonparametric analysis (Kruskall-Wallis).
Results
Figure 1 shows plasma cholesterol (A) and the cholesterol and spingolipid content in left ventricular myocytes (B).
The plasma content of LDL cholesterol was increased in LDLr −/− mice, and the HDL cholesterol was decreased in ApoA1 −/− mice compared with WT mice. This was associated with an increase of the cholesterol and a decrease of the sphingholipid content in ventricular myocytes of both LDLr −/− and ApoA1 −/− compared with WT mice ( Figure 1B ). The alteration in cholesterol content did not change body weight, the heart weight/body weight ratio, or the cellular capacitance ( Figure 1C ). Figure 2 shows typical examples of lead I surface ECG recordings ( Figure 2A ) and AP (6 Hz) and the corresponding dV/dt in left ventricular myocytes ( Figure 2B ). Overall, the QTc interval was significantly increased in both LDLr −/− and ApoA1 −/− compared with WT mice ( Figure 2C , left panel). We did not detect differences in RR interval, PQ interval, and QRS duration. In line with the increased QTc interval, AP duration at 90% of repolarization was prolonged in both LDLr −/− and ApoA1 −/− compared with WT mice ( Figure 2C , middle panel, pacing frequency 6 Hz). The upstroke velocity of the AP in both LDLr −/− and ApoA1 −/− was ≈30% decreased compared to WT mice ( Figure 2C , right panel) without a difference in resting membrane potential and the amplitude of the AP. Figure 3A shows typical examples of arrhythmias induced by 3 shortly coupled premature stimuli during regional ischemia (trace a, single spontaneous premature beat; trace b, VT; trace c, VF). The prevalence of arrhythmias in hearts from the 3 groups of mice is shown in Figure 3B . In all 3 groups, practically all hearts displayed ≥1 episodes of spontaneous premature beats. However, the percentage of hearts displaying ≥1 episodes of VT or VF was significantly lower in dyscholesterolemic mice than in WT mice. The total occurrence of arrhythmias (1 or 2 premature beats and VT/VF) was not statistically different between the groups: % of attempts WT, 17.1±2. Figure 3C shows the incidence of one or two premature beats after 3 shortly coupled stimuli during subsequent 10 minutes of ischemia, as well as the incidence during the entire 30-minute ischemic period. The incidence of extrasystoles was higher in the LDLr −/− and ApoA1 −/− hearts compared with WT hearts. In contrast, the incidence of tachycardia or VF ( Figure 3D ) was significantly lower in both LDLr −/− and ApoA1 −/− hearts compared with WT hearts. −/− mice, respectively. We next measured the major currents active during the plateau and repolarization phases of the AP to elucidate the mechanism underlying the longer APS in LDLr −/− and ApoA1 −/− mice. I Ca,L was investigated using a 2-step protocol ( Figure 4A ) consisting of series of depolarizing pulses (P1) to activate I Ca,L followed by a second depolarization to 0 mV (P2) to establish the voltage dependency of inactivation. , and WT mice ( Figure 4D ). The decay of I Ca,L (fitted with a double exponential function) was similar for the 3 groups (data not shown). K + currents were measured during 5 s hyperpolarizing and depolarizing voltage clamp steps from a holding potential of -80 mV (voltage protocol; Figure 5A ). Figure 5B shows representative current recordings in response to hyperpolarizing pulses to -120 mV and depolarizing pulses to 50 mV in WT, ApoA1 −/− , and LDLr −/− myocytes. Mean densities of steady-state currents, reflecting the inward rectifier current (I K1 ) and the noninactivating Kv current (I SS ), were similar for the 3 groups ( Figure 5C ). The mean density of the total peak transient current ( Figure 5D) ] i on RC in 6 Hz stimulated isolated ventricular myocytes ( Figure 6A ). In the LDLr −/− and ApoA1 −/− mice, the mean amplitude of the calcium transient was significantly increased compared with that in WT, without a significant change of diastolic calcium ( Figure 6B ). Also, time to peak and the 80% recovery were similar in the 3 groups (data not shown). Moreover, the [Ca 2+ ] i rise in response to RC was similar in LDLr −/− and ApoA1 −/− mice as compared with Figure 6B , right panel). Of note, with the given sample sizes, the minimum difference in SR content we could detect between the WT group and the LDLr −/− or the ApoA1 −/− group was 9% and 14%, respectively (power analysis).
In myocytes from LDLr
−/− mice, we applied 1 μmol/L verapamil to decrease the L-type calcium current with 31.2±1.2%. Table 2 shows that the effect of such a decrease results in almost complete normalization of AP duration and calcium transient amplitude, similar to values of WT mice, without significant effects on diastolic calcium and the amplitude of the calcium increase after RC.
To have an indication whether the increased calcium transient resulted from altered expression levels of membrane proteins, we measured mRNA levels. Figure 7A shows the averaged data (expressed as ratio to Gapdh and normalized to WT) in ApoA1 −/− , LDL −/− , and WT mice. No significant difference of relative mRNA levels of Caveolin-3, L-type Ca 2+ -channel, the cardiac Na + -channel or of the calcium handling proteins (sarcoplasmatic calcium pump, sodium calcium exchanger, and ryanodine receptor channels) were observed between the transgenic and WT mice. Also, no difference was found when the household gene Hprt was used.
Because we did not find a difference in mRNA expression levels of the L-type calcium channels but an increased current in ApoA1 −/− and LDL −/− mice compared with WT mice, we performed Western blot analysis of the L-type calcium channels. Figure 7B shows a typical example of a Western blot (top panel) and the average data: protein signal densities were normalized to the corresponding Gapdh signal densities (bottom panel). We did not find significant differences in protein level of the L-type calcium channels in ApoA1 −/− and LDLr −/− mice compared with WT mice.
Discussion
This study shows that in 2 different lines of dyscholesterolemic mice, cellular cholesterol levels are increased and sphingolipid content is decreased. In both types of dyscholesterolemic mice, the ventricular AP duration and the electrocardiographic QTc interval were increased. Besides, there was a 25% reduction in the upstroke velocity of the AP, indicating a reduction of I Na . Thus, the abnormal cholesterol and sphingolipid metabolism resulted in an inherent class III antiarrhythmic effect. This conclusion was supported by our observation that hearts from dyscholesterolemic mice were relatively protected against ischemia-induced ventricular tachyarrhythmias during acute regional myocardial ischemia. We established that the mechanism underlying the increased AP duration was an increase of I Ca,L . The increment in calcium current was associated with increased calcium transient amplitudes in the LDLr −/− and ApoA1 −/− mice, in the presence of an unchanged loading of the SR. Notably, the cellular and organismal electrophysiological effects were observed in the absence of circulating cholesterol. The observed changes were not associated with changes in mRNA of the L-type Ca-channel, the cardiac sodium channel, and calcium handling proteins (sarcoplasmatic calcium pump, sodium calcium exchanger, and ryanodine receptor channels). Neither was the protein expression of the L-type calcium channel changed in LDL −/− and ApoA1 −/− mice compared with WT mice. Major risk factors for cardiovascular disease include saturated fats and LDL cholesterol 1 (serum levels). Conversely, polyunsaturated fatty acids and HDL are thought to prevent or attenuate cardiac disease processes. 27, 28 High levels of cholesterol may protect from primary VF in patients with an MI, as suggested by the observation that in patients with an increased risk for VF after MI, hypercholesteremia was less common than in control MI patients. 2 The AP prolongation that we have documented in dyscholesterolemic mice offers an explanation for this antifibrillatory effect. Several other studies also suggest that dyscholesterolemia affects AP duration. Obese patients with high levels of cholesterol display prolongation of the QT interval.
8 LDL-lowering therapy with atorvastatin shortens QT segment in patients with advanced chronic heart failure, 6 and infusion of reconstituted HDL in patients with familial hypercholesterolemia induces QT shorterning 7 The LDL −/− mouse line is characterized by an increased serum LDL cholesterol and the ApoA1 −/− mouse line by a decreased serum HDL cholesterol. Although cholesterol levels are differentially affected in these mice, the electrophysiological effects of these changes were virtually the same. This suggests that the effects are the result of changes in cholesterol and sphingolipid content of the plasma membrane. The distribution of the membrane content of cholesterol and sphingolipids follows a similar pattern. The plasma membrane contains between 50% and 90% of the total cellular cholesterol and >50% of the total sphingolipid content. [29] [30] [31] Mitochondria and the sarcoplasmic reticulum have low cholesterol and sphingolipid content, whereas the Golgi compartment contains intermediate amounts of cholesterol. In addition, it has been suggested that the cholesterol and sphingolipid content of the plasma membrane are inversely related, 30 which is in agreement with our results and the delivering of cholesterol by LDL to membranes and the efflux of deposited cholesterol by HDL cholesterol. 32 Thus, unbalanced lipoprotein levels may cause cholesterol to accumulate in the plasma membrane, which also influences sphingolipid content. We cannot rule out that cholesterol and sphingolipid content is also altered in intracellular membranes, for example, the sarcoplasmic reticulum. However, the observation that pharmacological inhibition of I Ca,L by ≈30% in myocytes from LDLr −/− mice resulted in almost complete normalization of the AP and calcium handling (Table 2) suggests that SR function has not changed. Moreover, the absence of alterations in body and heart weight and cell capacitance ( Figure 1C) indicates that cardiac remodeling has not occurred. This is in line with previous studies that report no development of cardiac structural cardiac changes or atherosclerosis at this age in these mouse lines. 13, 14 Overall, these data suggest that the increased plasma membrane cholesterol levels have mediated the electrophysiological effects.
We cannot exclude the presence of microstructural changes, such as alterations in the structure of caveolae and the specialized cholesterol-and sphingolipid-enriched membrane microdomains that contain the structural protein caveolin-3. Cardiac ion channels, including L-type calcium and Na + channels, 4 have been associated with caveolae, which are involved in regulation of ion channel function. Nevertheless, we did not find differences in expression levels of caveolin-3.
Modulation of membrane lipid composition because of a fish oil diet has been shown to shorten the cardiac AP and to protect from triggered activity, but to cause reentrant arrhythmias, 12 suggesting that lipid modulation of the diet has important implications for cardiac arrhythmias depending on the mechanism of the arrhythmia. We here report that when all the trigger-induced arrhythmias (ie, the total number of ventricular extra systole+VT+VF) are included in the analysis of arrhythmia indelibility, no differences between groups were evident. However, although the number of spontaneous premature beats (triggers) was the same in the different groups, the incidence of VT/VF was lower, with periods of shorter duration and longer cycle length in the dyscholesterolemic mice. This implies a difference in arrhythmogenic substrate, but not in its triggers.
The 30% reduction of the AP upstroke velocity occurred in the absence of depolarization of the resting membrane. It has been shown that AP upstroke velocity is an adequate measure of I Na , 23 and this finding indicates that sodium current density is decreased with ≈30% and lies at the basis of this phenomenon. This is in agreement with previously published results in a rabbit model of hypercholesterolemia where a 40% increase of plasma membrane cholesterol content was associated with a 38% decrease in I Na in ventricular myocytes, without a change of inactivation of I Na . 33 Together, these data suggest that alterations of I Na are not the cause of the AP and QTc prolongation.
A modest reduction of sodium current does not lead to conduction slowing in itself 34 and may therefore not have influenced the class III antiarrhythmic effect of dyscholesterolemia in the conditions of our study. On the other hand, in the setting of, for example, the Brugada Syndrome, a small reduction in sodium current may provoke the typical electrocardiographic signs (right precordial ST-segment elevation) and arrhythmias in the presence of preexisting structural abnormalities. 35 It has been reported that the Brugada electrocardiographic sign can be provoked by a heavy meal (full stomach test). 36 Our experimental observation may underlie the mechanism of this provocation test, although it can also be explained by increased vagal tone.
Action Potential Duration
Changes in the level of membrane cholesterol have been shown to regulate multiple types of K + -channels. 3 We found a significant increase in I Ca,L to be responsible for the AP prolongation. The increase of I Ca,L is consistent with augmentation of I Ca,L in myocytes from portal vein of rabbits with dietary atherosclerosis 37 and the reduction of I Ca,L in skeletal muscle of mice with cholesterol depletion . 38 On the contrary, it has been described that cholesterol enrichment inhibits I Ca,L channels in gall bladder cells of guinea pigs treated with cholesterol-saturated cyclodextrin complex 39 and in myocytes from conduit coronary arteries of hypercholesterolemic miniature swine. 40 
Calcium Handling
We show that the altered myocyte function was not because of altered protein expression levels, indicating that alteration of the lipid composition of the plasma membrane directly modulates cardiac electrophysiology and arrhythmogenesis in the absence of structural abnormalities of the vessels. A variety of ion channels have been shown to be sensitive to changes in membrane cholesterol, among which are ion channels that influence AP characteristics. 3 In our 2 models of dyscholesterolemia, the amplitude of the calcium transient was increased without a significant increase in SR calcium content, alteration of calcium transient characteristics, or increase in diastolic calcium. This indicates that the trigger to release calcium from the SR, that is, the calcium influx through the L-type calcium channels, was increased. Indeed, fractional SR calcium release and the I Ca,L were larger in the 2 dyscholesterolemic mouse models. Because the minimum detectable difference in SR calcium content between the WT and the LDLr −/− or ApoA1 −/− groups was 9% and 14% respectively, we cannot rule out that the increase of the calcium transient was in part as a result of a small increase of the SR calcium content. However, pharmacological normalization of I Ca,L in LDLr −/− mice ( Table 2 ) resulted in an almost complete normalization of the calcium transient amplitude, fractional SR release, and AP duration, indicating that increased I Ca,L is the main contributor. The observed altered calcium homeostasis is in agreement with other studies. 41, 42 We did not observe an increased diastolic calcium in dyscholesterolemic mice, which can be explained by a secondary increase in sodium calcium exchanger activity after the increased amplitude of the calcium transient.
Two general mechanisms have been proposed for alteration of the lipid content of the sarcolemma of regulation of ion channels. One possibility is that cholesterol may interact directly with the transmembrane domains of the ion channels. 43 We observed antiarrhythmic electrophysiological changes both in the presence and in the absence of circulating cholesterol, making direct binding a less likely mechanistic option. Another explanation is that the increased cholesterol content may regulate ion channels by hydrophobic mismatch between the transmembrane of domains and the lipid bilayer. In this case, a stiffer membrane will increase the energy that is required for the transition from closed to open states of the channel and thus influence the ion channel kinetics. 44 These mechanisms are not mutually exclusive, and our methods do not allow discrimination between these possibilities, although we were not able to detect changes in ion channel kinetics ( Figure 4D) .
Also, we cannot entirely rule out that the subunit isoform type of ion channels and phosphorylation state of the myocytes are influenced by alteration of the lipid composition of the sarcolemma. We did not find alterations in decay or activation and inactivation characteristic of the L-type calcium channel, nor changes in the calcium transient decay and SR calcium content, 2 characteristics found in myocytes with an increased phosphorylation state. Therefore, changes in subunit type and altered phosphorylation state are not likely to be responsible for the observed changes.
Conclusions
Our study shows that dyscholesterolemia alters the lipid content of cardiac myocytes. This affects ion channel properties underlying I Na and I Ca,L , resulting in a decrease of upstroke velocity and increased duration of the AP and QT duration of the ECG. These electrophysiological changes resulted in reduced inducibility of lethal arrhythmias induced by acute MI. Thus, altered cholesterol homeostasis is an important modifier of cardiac electrophysiology. Change of sarcolemmal cholesterol levels (depending on the underlying pathophysiology of altered electrophysiological characteristics) without increasing plasma cholesterol levels may provide the basis of therapeutic interventions to alter cardiac electrophysiology and to reduce arrhythmogenesis especially in dyslipidemic patients.
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